- Home
- ELMD vs AVR Comparison
ELMD vs AVR Comparison
Compare ELMD & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- AVR
- Stock Information
- Founded
- ELMD 1992
- AVR 1999
- Country
- ELMD United States
- AVR Australia
- Employees
- ELMD N/A
- AVR N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AVR
- Sector
- ELMD Health Care
- AVR
- Exchange
- ELMD Nasdaq
- AVR NYSE
- Market Cap
- ELMD 229.6M
- AVR 241.5M
- IPO Year
- ELMD 2010
- AVR 2024
- Fundamental
- Price
- ELMD $22.79
- AVR $2.88
- Analyst Decision
- ELMD Strong Buy
- AVR Strong Buy
- Analyst Count
- ELMD 1
- AVR 4
- Target Price
- ELMD $38.00
- AVR $16.50
- AVG Volume (30 Days)
- ELMD 64.9K
- AVR 408.9K
- Earning Date
- ELMD 05-06-2025
- AVR 05-16-2025
- Dividend Yield
- ELMD N/A
- AVR N/A
- EPS Growth
- ELMD 66.51
- AVR N/A
- EPS
- ELMD 0.75
- AVR N/A
- Revenue
- ELMD $59,626,000.00
- AVR $2,703,000.00
- Revenue This Year
- ELMD $17.91
- AVR $29.52
- Revenue Next Year
- ELMD $11.70
- AVR $204.83
- P/E Ratio
- ELMD $30.44
- AVR N/A
- Revenue Growth
- ELMD 15.35
- AVR N/A
- 52 Week Low
- ELMD $13.74
- AVR $2.34
- 52 Week High
- ELMD $35.56
- AVR $8.79
- Technical
- Relative Strength Index (RSI)
- ELMD 39.65
- AVR N/A
- Support Level
- ELMD $22.39
- AVR N/A
- Resistance Level
- ELMD $23.18
- AVR N/A
- Average True Range (ATR)
- ELMD 0.97
- AVR 0.00
- MACD
- ELMD 0.15
- AVR 0.00
- Stochastic Oscillator
- ELMD 58.81
- AVR 0.00
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.